Study on the correlation between sleep disturbance and growth hormone deficiency in polycystic ovary syndrome

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100046266

Enrollment

Unknown

Registered

2021-05-12

Start date

2021-06-01

Completion date

Unknown

Last updated

2021-12-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

polycystic ovary syndrome

Interventions

case series:Nil

Eligibility

Sex/Gender

Female

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 50 years; 2. First visit to the Reproductive Health and Infertility Department of our hospital; 3. Patients with polycystic ovary syndrome previously diagnosed or initially diagnosed. The diagnostic criteria are the 2018 International Evidence-Based Guidelines for Polycystic Ovary Syndrome. 4. Willing to participate in this research and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Have a history of surgery on either side of the ovary, endometriosis stage III, IV, combined with effusion of either side of the fallopian tube; 2. Combined with uncontrolled thyroid disease, hyperprolactinemia; 3. Diagnosed as type I or type II diabetes, high blood pressure; 4. Chromosomal abnormalities (chromosome polymorphisms are not excluded).

Design outcomes

Primary

Measure	Time frame
Growth Hormone;Insulin-like growth factor;Insulin-like growth factor binding protein-3;Pittsburgh Sleep Quality Index;	—

Countries

China

Contacts

Public ContactSu Nianjun

Guangdong Women and Children Hospital

kens24@163.com+86 13416266097

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026